Common medications in this class include: Ozempic (semaglutide) Wegovy (semaglutide) Rybelsus (semaglutide) Mounjaro (tirzepatide) Zepbound (tirzepatide) Trulicity (dulaglutide) While many users experience common, milder side effects like nausea, a growing number of individuals are reporting severe, persistent, and life-altering gastrointestinal injuries
Serious health issues, such as stroke, cardiovascular disease, diabetes, and even specific types of cancer, are linked to obesity
Give each dose level at least two weeks before bumping it up, says Defnet
Only one participant in the semaglutide group experienced an adverse event requiring hospitalization
The primary outcome was a reversal of shock at 48 hours